We were able to characterize the exhausted state of TAA-specific CD8+ T cells and immunosuppressive cell populations in the TME in the model, indicating that it can be a suitable preclinical model for exploration and evaluation of immune checkpoint inhibitors and cell-based immunotherapies for HCC treatment. This evidence concerns the gene CD8A and hepatocellular carcinoma.